Clinical Trial Results:
Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit einer Nystatin (100 000 I.E./g)/Hydrocortisonacetat (5 mg/g) -haltigen Paste vs. einer Nystatin (100 000 I.E./g) -haltigen Paste ohne Hydrocortisonacetat bei Patienten mit mittelschwer bis schwer entzündlicher Candidose der Haut
English title: Double-blind, randomised clinical study to compare the efficacy and safety of a nystatine (100 000 I.U./g)/hydrocortisone acetate (5 mg/g) -containing paste vs. a nystatine (100 000 I.U./g) -containing paste without hydrocortisone acetate in patients with moderate to severe inflamed candidiasis of the skin
Summary
|
|
EudraCT number |
2006-004759-39 |
Trial protocol |
DE |
Global completion date |
03 Mar 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Dec 2016
|
First version publication date |
04 Dec 2016
|
Other versions |
|
Summary report(s) |
Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.